Partner Series

-

Join ETF Securities as we partner with Australian and international investment professionals to discuss the latest market and economic issues and what this means for investments. You’ll find the latest videos and articles on this page or subscribe using the purple subscribe button on the top right hand side of the page to receive the weekly updates.

Latest articles

partner-series-default-image.png
Uncertainty and periods of volatility are an expected part of life as well as financial markets and investors should be considering how to factor these into their investment strategies. While there’s no easy fix strategy that can be used for all investors, effective strategies tend to share a few aspects in common. Kanish Chugh, co-Head of Sales at ETF Securities, discussed investment strategies for uncertain times with Andrew Connors, Founder and Director of Quilla, one of Australia’s leading independent investment consultants serving financial advisers and institutional investors. The characteristics of a good investment strategy A good strategy will be tailored to the individual investor’s needs, goals and circumstances but there are a few aspects that should hold true regardless. “You can’t avoid diversification. It’s still the only free lunch you get with investing, and what I mean by that is you can invest in two securities that, in combination, mitigate some of the risks of each of those securities individually, without necessarily impacting the return,” says Mr Connors. ...
partner-series-default-image.png
The search for cures and vaccines during the COVID-19 pandemic has brought the biotechnology industry into sharp focus. Beyond the COVID-19 pandemic though, what does the future hold for this industry and the broader healthcare sector? Kanish Chugh, co-Head of Sales at ETF Securities, discussed the future of biotechnology and healthcare with Scott Power, Senior Analyst covering Healthcare, Life Science and Technology for Morgans Financial Limited. Defining healthcare and biotechnology The healthcare sector represents all businesses providing medical goods and services to treat patients. ...
partner-series-default-image.png
Blue chip is synonymous with quality and dividends in the mind of the Australian investor, but are the companies considered as the blue chips of today likely to remain as the blue chips of tomorrow? The ability to generate a consistent dividend stream has been a mainstay of those companies we deem blue chip but in the wake of COVID-19 related dividend cuts, does the Australian view of blue chip need to evolve? Kanish Chugh, co-Head of Sales at ETF Securities, discussed the future of blue-chip investing with Peter Green, Head of Listed Products for Lonsec Research and James Gerrish, Portfolio Manager for Shaw and Partners and author of investment newsletter, Market Matters. Defining a blue chip investment “Blue chips have been in the past large size, industry leaders, well run and in the Australian context, very much also looking at dividends and fully franked dividends. So, we’re talking companies like the big four banks, Telstra,” says Mr Green. ...